Roxan Ara
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
-
- Extracellular vesicles in disease 8
- Angiogenesis and VEGF in Cancer 2
- Immunology 12
- Immune cells in cancer 9
- Immunotherapy and Immune Responses 3
- Co-authors
- Ali S. Arbab (25 shared papers)Mohammad H. Rashid (19 shared papers)Bhagelu R. Achyut (17 shared papers)Thaiz F. Borin (16 shared papers)Kartik Angara (17 shared papers)Yutao Liu (6 shared papers)Asm Iskander (12 shared papers)Adarsh Shankar (8 shared papers)
- Journals
- Cancer Research (8 papers)PLoS ONE (2 papers)Scientific Reports (2 papers)Nanomedicine Nanotechnology Biology and Medicine (1 paper)Cancer Biology & Therapy (1 paper)
- Partner nations
- United StatesEgyptGeorgia
In The Last Decade
Roxan Ara
25 papers receiving 613 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 225
- Genetics 108
- Immunology 188
- Molecular Biology 359
- Oncology 117
Countries citing papers authored by Roxan Ara
This map shows the geographic impact of Roxan Ara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxan Ara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxan Ara more than expected).
Fields of papers citing papers by Roxan Ara
This network shows the impact of papers produced by Roxan Ara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxan Ara. The network helps show where Roxan Ara may publish in the future.
Co-authors
The 25 scholars most cited alongside Roxan Ara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 97 | |
| 2 | 2019 | 78 | |
| 3 | 2018 | 59 | |
| 4 | 2021 | 59 | |
| 5 | 2015 | 46 | |
| 6 | 2017 | 46 | |
| 7 | 2017 | 38 | |
| 8 | 2017 | 24 | |
| 9 | 2021 | 22 | |
| 10 | 2021 | 21 | |
| 11 | 2017 | 21 | |
| 12 | 2017 | 19 | |
| 13 | 2020 | 17 | |
| 14 | 2016 | 16 | |
| 15 | 2016 | 15 | |
| 16 | 2021 | 14 | |
| 17 | 2018 | 9 | |
| 18 | 2017 | 8 | |
| 19 | 2019 | 2 | |
| 20 | 2019 | 2 |
About Roxan Ara
Roxan Ara is a scholar working on Molecular Biology, Immunology, Cancer Research, Genetics and Oncology, having authored 27 papers that have together received 618 indexed citations. Recurring topics across this work include Immune cells in cancer (9 papers), Extracellular vesicles in disease (8 papers), Glioma Diagnosis and Treatment (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Immunotherapy and Immune Responses (3 papers), MicroRNA in disease regulation (3 papers), Cancer Cells and Metastasis (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Cancer Research (225 citations), Genetics (108 citations), Immunology (188 citations), Molecular Biology (359 citations) and Oncology (117 citations). Roxan Ara has collaborated with scholars based in United States, Egypt and Georgia. Frequent co-authors include Ali S. Arbab, Mohammad H. Rashid, Bhagelu R. Achyut, Thaiz F. Borin, Kartik Angara, Yutao Liu, Asm Iskander, Adarsh Shankar, Meenu Jain and Iryna Lebedyeva. Their work appears in journals such as Cancer Research, PLoS ONE, Scientific Reports, Nanomedicine Nanotechnology Biology and Medicine and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.